Literature DB >> 28074536

Use of an intravenous sclerosing foam (3% sodium tetradecyl sulfate) for treatment of orbital varix in a dog.

Rebecca S Saunders1, Brian A Scansen1, Stephen S Jung2, Hooman Khabiri3, David A Wilkie1.   

Abstract

A 6-month-old intact male Standard Dachshund was referred for evaluation of a soft tissue swelling above the right eye. Examination of the right eye revealed mild lateral deviation of the globe, normal vision, and a dorsonasal soft tissue swelling. Examination of the posterior segment was normal. Dual-phase computed tomography angiography was consistent with an orbital varix of the angularis oculi and right dorsal external ophthalmic veins with no evidence of arterial involvement. Treatment involved fluoroscopically guided coil embolization of the venous outflow with nine platinum microcoils, followed by sclerotherapy of the varix using 1.5 mL of 3% sodium tetradecyl sulfate foam. Moderate-to-marked swelling was noted at the treatment site in the weeks following therapy, which gradually resolved. At final reexamination 3 months post-therapy, complete sclerosis and resolution of the orbital varix were documented. To the authors' knowledge, this is the first reported case involving the use of a sclerotic agent for successful treatment of a venous malformation in a dog.
© 2017 American College of Veterinary Ophthalmologists.

Entities:  

Keywords:  canine; interventional radiology; sclerotherapy; sotradecol; vein; venous malformation

Mesh:

Substances:

Year:  2017        PMID: 28074536     DOI: 10.1111/vop.12456

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  2 in total

1.  Penile Varicose Vein in Akita inu, 7-Year-Old Dog: A Clinico-Pathological Study.

Authors:  Simona Attard; Luisa Vera Muscatello; Giuseppe Mazzullo; Maria Carmela Pisu
Journal:  Vet Sci       Date:  2022-01-27

2.  Polidocanol monotherapy for a superficial orbital venous malformation in a horse.

Authors:  Tara M Stonex; Ashley E Zibura; Michael Andres; Brian C Gilger; Annie Oh
Journal:  Vet Ophthalmol       Date:  2022-06-01       Impact factor: 1.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.